Partitioning of thioridazine and mesoridazine in human blood fractions
- PMID: 6748818
Partitioning of thioridazine and mesoridazine in human blood fractions
Abstract
The partitioning of 3H-thioridazine and 3H-mesoridazine in fresh human whole blood was studied. The packed red blood cells were solubilized using the New England Nuclear protocol for whole blood solubilization. The plasma fraction was further fractionated into protein bound and free drug by molecular ultrafiltration. All solutions were counted in Biofluor LSC cocktail and corrected for quenching. Greater than 99% of the labeled drug was bound to the red blood cells and plasma protein. For thioridazine, 59% is bound to RBC, 41% is bound to plasma protein and 0.7% is free; for mesoridazine, 63% is bound to RBC, 37% is bound to plasma protein and 0.9% is free. Though substantial overlap is found in the bound percentage for mesoridazine and thioridazine, more mesoridazine binds to RBC than thioridazine (p less than 0.01). There is no statistically significant relationship between the amount of drug bound to the RBC or to plasma protein and the percent free drug. Though the total drug concentration is the same (1 microgram/ml) the percent free drug is quite variable across subjects by as much as a factor of three. Since free drug is the pharmacologically active portion and therefore determinant of clinical response, the reported variation in free drug concentration at the same total blood concentration invalidates the measurements of total serum or plasma drug concentration as predictive of clinical response.
Similar articles
-
Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.Psychopharmacology (Berl). 1984;82(1-2):55-61. doi: 10.1007/BF00426381. Psychopharmacology (Berl). 1984. PMID: 6420831 Clinical Trial.
-
Identification of a metabolite of thioridazine and mesoridazine from human plasma.Res Commun Chem Pathol Pharmacol. 1975 Feb;10(2):221-5. Res Commun Chem Pathol Pharmacol. 1975. PMID: 1162173
-
Binding of thioridazine and some of its metabolites to human serum protein and human albumin.Arzneimittelforschung. 1975;25(12):1969-71. Arzneimittelforschung. 1975. PMID: 1243669
-
Mesoridazine -- a pharmacodynamic and pharmacokinetic profile.J Clin Psychiatry. 1981 Dec;42(12):463-9. J Clin Psychiatry. 1981. PMID: 7031039 Review.
-
The pharmacokinetics of some psychoactive drugs and relationships to clinical response.Methods Find Exp Clin Pharmacol. 1985 May;7(5):275-82. Methods Find Exp Clin Pharmacol. 1985. PMID: 3897748 Review.
Cited by
-
The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.Eur J Drug Metab Pharmacokinet. 1986 Oct-Dec;11(4):283-9. doi: 10.1007/BF03189113. Eur J Drug Metab Pharmacokinet. 1986. PMID: 3582423
-
Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine.Pharm Res. 1987 Jun;4(3):207-13. doi: 10.1023/a:1016451926984. Pharm Res. 1987. PMID: 3509283
-
Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis.Pharm Res. 2006 Jun;23(6):1133-43. doi: 10.1007/s11095-006-0070-7. Epub 2006 May 25. Pharm Res. 2006. PMID: 16715368